Moneycontrol PRO
Outskill Genai
HomeNewsBusinessStocksBEML may move to Rs 1815, buy Glenmark Pharma: Rajat Bose

BEML may move to Rs 1815, buy Glenmark Pharma: Rajat Bose

Rajat Bose of rajatkbose.com is of the view that one may buy Glenmark Pharma.

October 05, 2017 / 12:22 IST

Rajat Bose of rajatkbose.com told CNBC-TV18, "I am choosing BEML, keep stoploss of Rs 1,684 and I am looking at Rs 1,800-1,815. It is a two-three trading sessions kind of a trade and DHFL has already moved up quite a bit, today’s target has been Rs 580 but it is headed for Rs 595 to about Rs 603 on the upside."

"In KPIT Technologies I would put a stoploss below Rs 124 and Rs 129.75 to about Rs 131 could be the target. There is a good amount of F&O position building as well."

"Glenmark Pharma has an excellent chart, even it can be bought for investments at current levels given the chart pattern. Stoploss below Rs 608 and looking at Rs 640 for today but once Rs 640 is decisively taken out, Rs 675-680 would be the next target. So Glenmark is still a buy," he added.

first published: Oct 5, 2017 12:22 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347